The heart in Wilson's disease: Difference between revisions

Jump to navigation Jump to search
(New page: {{WikiDoc Cardiology Network Infobox}} {{SI}} {{EH}} Category:Cardiology {{SIB}} {{WikiDoc Help Menu}} {{WikiDoc Sources}})
 
No edit summary
Line 3: Line 3:
{{EH}}
{{EH}}


==Overview==
[[Wilson's disease]] affects multiple systems.  Various medical conditions have been linked with the copper accumulation that accompanies Wilson's, including [[cardiomyopathy]] (weakness of the heart muscle), which is a rare but recognized problem; it may lead to [[heart failure]] (fluid accumulation due to decreased pump function) and [[cardiac arrhythmia]]s (episodes of irregular and/or abnormally fast or slow heart beat)
==Clinical Findings==
A 10-year, prospective study with 53 patients reported that there are four group of clinical symptoms in Wilson’s disease.<ref>Kuan P, Cardiac Wilson's disease Chest 1987; 91; 579-583 DOI 10.1378/chest.91.4.579 </ref> At the beginning of this study (at the time of presentation), cardiovascular abnormalities were not noted in any of these patients (all the patients in this report presented without any cardiac symptoms);
*Arrhythmias: More than 50% of patients have ECG signs of left ventricular hypertrophy, biventricular hypertrophy, early repolarization, and ST depression and T inversion, premature atrial or ventricular contractions, atrial fibrillation, sinoatrial block, Mobitz type 1 atrioventricular block. Tremor artifacts during ECG examinations in patients with Wilson's disease should also been considered (Resting tremors of the arms constitute the major problem in patients with Wilson's Disease).
*Cardiomyopathy; interstitial fibrosis and [[myocarditis]],
*Cardiac Death; ventricular fibrillation and complications of cardiomyopathies
*Autonomic Dysfunction: abnormal response to the [[Valsalva maneuver]]
==Histopathological Findings==
According to a 9 patient’s histological study the main characteristics are;
*Interstitial fibrosis,
*Sclerosis of the intramyocardial small vessels 
*Perivascular myocarditis.
In autopsy results, myocardial copper concentrations in cardiac [[Wilson's disease]] patients went from low (2.28 μgm / g18) to high (1.428 μgm / g).  The differing results could have arisen from varying responses to copper chelating therapy.  The increased copper didn't seem to correspond to the severity of the myocardial lesions. <ref> Factor SM, Cho S, Sternlieb I, Scheinberg IH, Goldfischer S. The cardiomyopathy of Wilsonıs disease: myocardial alteration in nine cases. Virchow’s Arch A Pathol Anat 1982; 397:301-11</ref>
==References==
{{reflist|2}}


[[Category:Cardiology]]
[[Category:Cardiology]]

Revision as of 17:47, 4 May 2009

Cardiology Network

Discuss The heart in Wilson's disease further in the WikiDoc Cardiology Network
Adult Congenital
Biomarkers
Cardiac Rehabilitation
Congestive Heart Failure
CT Angiography
Echocardiography
Electrophysiology
Cardiology General
Genetics
Health Economics
Hypertension
Interventional Cardiology
MRI
Nuclear Cardiology
Peripheral Arterial Disease
Prevention
Public Policy
Pulmonary Embolism
Stable Angina
Valvular Heart Disease
Vascular Medicine

WikiDoc Resources for The heart in Wilson's disease

Articles

Most recent articles on The heart in Wilson's disease

Most cited articles on The heart in Wilson's disease

Review articles on The heart in Wilson's disease

Articles on The heart in Wilson's disease in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on The heart in Wilson's disease

Images of The heart in Wilson's disease

Photos of The heart in Wilson's disease

Podcasts & MP3s on The heart in Wilson's disease

Videos on The heart in Wilson's disease

Evidence Based Medicine

Cochrane Collaboration on The heart in Wilson's disease

Bandolier on The heart in Wilson's disease

TRIP on The heart in Wilson's disease

Clinical Trials

Ongoing Trials on The heart in Wilson's disease at Clinical Trials.gov

Trial results on The heart in Wilson's disease

Clinical Trials on The heart in Wilson's disease at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on The heart in Wilson's disease

NICE Guidance on The heart in Wilson's disease

NHS PRODIGY Guidance

FDA on The heart in Wilson's disease

CDC on The heart in Wilson's disease

Books

Books on The heart in Wilson's disease

News

The heart in Wilson's disease in the news

Be alerted to news on The heart in Wilson's disease

News trends on The heart in Wilson's disease

Commentary

Blogs on The heart in Wilson's disease

Definitions

Definitions of The heart in Wilson's disease

Patient Resources / Community

Patient resources on The heart in Wilson's disease

Discussion groups on The heart in Wilson's disease

Patient Handouts on The heart in Wilson's disease

Directions to Hospitals Treating The heart in Wilson's disease

Risk calculators and risk factors for The heart in Wilson's disease

Healthcare Provider Resources

Symptoms of The heart in Wilson's disease

Causes & Risk Factors for The heart in Wilson's disease

Diagnostic studies for The heart in Wilson's disease

Treatment of The heart in Wilson's disease

Continuing Medical Education (CME)

CME Programs on The heart in Wilson's disease

International

The heart in Wilson's disease en Espanol

The heart in Wilson's disease en Francais

Business

The heart in Wilson's disease in the Marketplace

Patents on The heart in Wilson's disease

Experimental / Informatics

List of terms related to The heart in Wilson's disease

Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [1] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

Overview

Wilson's disease affects multiple systems. Various medical conditions have been linked with the copper accumulation that accompanies Wilson's, including cardiomyopathy (weakness of the heart muscle), which is a rare but recognized problem; it may lead to heart failure (fluid accumulation due to decreased pump function) and cardiac arrhythmias (episodes of irregular and/or abnormally fast or slow heart beat)

Clinical Findings

A 10-year, prospective study with 53 patients reported that there are four group of clinical symptoms in Wilson’s disease.[1] At the beginning of this study (at the time of presentation), cardiovascular abnormalities were not noted in any of these patients (all the patients in this report presented without any cardiac symptoms);

  • Arrhythmias: More than 50% of patients have ECG signs of left ventricular hypertrophy, biventricular hypertrophy, early repolarization, and ST depression and T inversion, premature atrial or ventricular contractions, atrial fibrillation, sinoatrial block, Mobitz type 1 atrioventricular block. Tremor artifacts during ECG examinations in patients with Wilson's disease should also been considered (Resting tremors of the arms constitute the major problem in patients with Wilson's Disease).
  • Cardiac Death; ventricular fibrillation and complications of cardiomyopathies

Histopathological Findings

According to a 9 patient’s histological study the main characteristics are;

  • Interstitial fibrosis,
  • Sclerosis of the intramyocardial small vessels
  • Perivascular myocarditis.

In autopsy results, myocardial copper concentrations in cardiac Wilson's disease patients went from low (2.28 μgm / g18) to high (1.428 μgm / g). The differing results could have arisen from varying responses to copper chelating therapy. The increased copper didn't seem to correspond to the severity of the myocardial lesions. [2]

References

  1. Kuan P, Cardiac Wilson's disease Chest 1987; 91; 579-583 DOI 10.1378/chest.91.4.579
  2. Factor SM, Cho S, Sternlieb I, Scheinberg IH, Goldfischer S. The cardiomyopathy of Wilsonıs disease: myocardial alteration in nine cases. Virchow’s Arch A Pathol Anat 1982; 397:301-11


Template:SIB


Template:WikiDoc Sources